by Camillo Ricordi | Oct 5, 2026 | Latest News
To the U.S. Department of Health and Human Services, Food and Drug Administration, and Health Resources and Services Administration: I support a carefully defined pathway to regulate isolated, otherwise unmodified pancreatic islets recovered from deceased donors for...
by Shelley Ross | Oct 1, 2026 | Latest News
Today The Cure Alliance is proud to announce two new partnerships that advance both halves of our mission: curing and preventing chronic, debilitating, and fatal diseases. First, we are supporting the research of Dr. Rumela Chakrabarti as she tests new ways to stop...
by Camillo Ricordi | Sep 14, 2026 | Latest News
From an Idea to a Registrational Pathway for Islet Transplantation This milestone represents the culmination of a remarkable scientific and translational journey that began nearly a decade ago. At NobleCon in 2018, Dr. Camillo Ricordi, as a member of Noble Capital...
by Piotr Witkowski | Sep 13, 2026 | Latest News
Stimulated by the extremely promising preliminary results from our pilot study involving 12 patients, Eledon Pharmaceuticals has submitted an IND application to the U.S. Food and Drug Administration (FDA). This represents the first and a very important step toward...
by Admin | Oct 27, 2025 | Latest News, Press Releases
Breaking News from 2025 Congress of Cell Transplantation and Regenerative Medicine Society TOKYO, JAPAN, October 27, 2025 /EINPresswire.com/ — At the 2025 Congress of the Cell Transplant and Regenerative Medicine Society Saturday, world-renowned expert Dr....
by Admin | Oct 29, 2024 | Latest News
Stunning Results of First Human Trials Presented Today in Boston at 5th Summit on Stem Cell Derived Islets MIAMI, FL, UNITED STATES, October 29, 2024 /EINPresswire.com/ — The Cure Alliance, a 501(c)(3) nonprofit, is excited to announce that three patients with type 1...
